[1] Skuse, A. (2015). Constructions of cancer in early modern England: ravenous natures (p. 219). Springer Nature.
[2] Heitzer, E., Auinger, L., & Speicher, M. R. (2020). Cell-free DNA and apoptosis: how dead cells inform about the living. Trends in molecular medicine, 26(5), 519-528.
[3] Brabec, V., & Nováková, O. (2006). DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resistance Updates, 9(3), 111-122.
[4] Tabatabaei Rezaei, S. J., Mashhadi Malekzadeh, A., Sarbaz, L., Niknejad, H., & Ramazani, A. (2020). Hyperbranched polymers functionalized magnetic nanoparticles for targeted delivery and intracellular release of cisplatin. Applied Chemistry, 15(54), 55-70. (in persian)
[5] Roos, W. P., & Kaina, B. (2006). DNA damage-induced cell death by apoptosis. Trends in molecular medicine, 12(9), 440-450.
[6] Wang, D., & Lippard, S. J. (2005). Cellular processing of platinum anticancer drugs. Nature reviews Drug discovery, 4(4), 307-320.
[7] Abbasi, P., & Shafaatian, B. (2020). Synthesis, Characterization, Fluorescence and Electrochemical Studies of New Ferrocene Schiff base ligand Containing Nitrogen Donor Atoms and Its Palladium (II), Nickel (II) and Copper (II) Complexes. Applied Chemistry, 15(55), 111-124. (in persian)
[8] Arabali, V. (2016). Electrocatalytic Determination of Captopril using NiO Nanoparticle/Acetylferrrocene Modified Electrode in Biological and Pharmaceutical Samples J. Of Applied Chemistry. 11 9. (in persian)
[9] Acevedo-Morantes, C. Y., Meléndez, E., Singh, S. P., & Ramírez-Vick, J. E. (2012). Cytotoxicity and reactive oxygen species generated by ferrocenium and ferrocene on MCF7 and MCF10A cell lines. J Cancer Sci Ther, 4(9), 271-275.
[10] Van Staveren, D. R., & Metzler-Nolte, N. (2004). Bioorganometallic chemistry of ferrocene. Chemical reviews, 104(12), 5931-5986.
[11] Nabavizadeh, S. M., Niroomand Hosseini, F., Niknam, F., Hamidizadeh, P., Hoseini, S. J., Ford, P. C., & Abu-Omar, M. M. (2019). Chelating and Bridging Roles of 2-(2-Pyridyl) benzimidazole and Bis (diphenylphosphino) acetylene in Stabilizing a Cyclic Tetranuclear Platinum (II) Complex. Inorganic chemistry, 58(21), 14608-14616.
[12] Imrie, C., Nyamori, V. O., & Gerber, T. I. (2004). Solvent-free synthesis of ferrocenylimines. Journal of organometallic chemistry, 689(9), 1617-1622.
[13] Frisch, M. J. (2009). Gaussian 09 revision A. 02. (No Title).
[14] Cossi, M., Scalmani, G., Rega, N., & Barone, V. (2002). New developments in the polarizable continuum model for quantum mechanical and classical calculations on molecules in solution. The Journal of Chemical Physics, 117(1), 43-54.
[15] Pagadala, N. S., Syed, K., & Tuszynski, J. (2017). Software for molecular docking: a review. Biophysical reviews, 9, 91-102.
[16] Schrödinger Release 2015-2: Schrödinger, (2015).
[17] Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., ... & Shenkin, P. S. (2004). Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of medicinal chemistry, 47(7), 1739-1749.
[18] T. A. Halgren, R. B. Murphy, R. A. Friesner, H. S. Beard, L. L. Frye, W. T. Pollard, J. L. Banks, Journal of medicinal chemistry. 47 (2004) 1750.
[19] Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., ... & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes. Journal of medicinal chemistry, 49(21), 6177-6196.
[20] Stevanović, D., Bertuzzi, G., Mazzanti, A., Fochi, M., & Bernardi, L. (2018). Catalytic Enantioselective Povarov Reactions of Ferrocenecarbaldehyde‐Derived Imines–Brønsted Acid Catalysis at Parts‐Per‐Million Level Loading. Advanced Synthesis & Catalysis, 360(5), 893-900.
[21] Benesi, H. A., & Hildebrand, J. H. J. (1949). A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. Journal of the American Chemical Society, 71(8), 2703-2707.
[22] Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert opinion on drug discovery, 10(5), 449-461.
)